“Door to Needle (DTN) Time in Stroke Thrombolysis” Audit Care of the Elderly Department Dr Nikoletta Petrou, Foundation Year 1 Doctor Dr Prasanna Aghoram,

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Stroke Workshop Case Scenario.
NICE HEAD INJURY GUIDELINES WHAT ARE THE GUIDELINES FOR THEIR INITIAL ASSESSMENT IN ED – All patients with a head injury should be assessed by an.
Accomplishments in Stroke Care
DISCLOSURE INFORMATION: Target: Stroke is an initiative provided by the American Heart Association/American Stroke Association. The University of California,
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
THROMBOLYSIS Alteplase: indications and contra-indications Dr Ken Fotherby, New Cross Hospital.
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
G.N. Dalekos3, M. Elisaf2, A.I. Hatzitolios1
Disclosures: Maximo C. Kiok, M.D. Medical Director of Stroke Program Trinity Health System.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
Target: Stroke Building on Success A national quality improvement initiative of the American Heart Association/American Stroke Association to improve.
Emily O’Brien, MSPH Predoctoral Trainee February 16, 2010 The North Carolina Stroke Care Collaborative Clinical Outcomes among Stroke Patients Receiving.
Stroke Mark Sudlow Consultant and Senior Lecturer
Head injury audit Dr Ivo Dukic, Senior House Officer in Emergency Medicine Ms Caroline Plant, Staff Nurse in Emergency Medicine Dr Feroz Rahim, Staff.
STROKE Dr Muhammah Ashraf Assistant Professor Medicine
Ann M. Hoff, MD ETC Physician Trinity Health. American Stroke Association  Guidelines for the Early Management of Adults with Ischemic Stroke (2007)
Stroke-treatment and management SAHD Naghme Adab.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,
Seeing a Stroke Developed by: K. Banasky, RN, BSN Educator GCH Emergency Services.
What can we do to cut down the time it takes to give a clot dissolving drug (tPA)?
Process to Improve Stroke Care Reduce time to brain imaging Partner with EMS to improve skills & early identification Enhanced ED response & evaluation.
 Describe the major signs and symptoms of stroke  Classify stroke and type specific treatments  Apply 8 d’s of stroke care  Follow suspected stroke.
FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4
Acute ischemic stroke: Not a moment to lose By Julie Miller, RN, CCRN, BSN, & Janice Mink, RN, CCRN, CNRN Nursing2009, May ANCC contact hours.
SYDNEY MEDICAL SCHOOL What do the IST-3 results mean for the elderly patient with acute stroke? Westmead Hospital Clinical School | George Institute for.
Supporting NHS Wales to Deliver World Class Healthcare All Wales Stroke Services Improvement Collaborative Learning Session One 21 st October 2009.
Face Stroke, Before it Faces You Welcome. Introduction Do you know a friend or relative who has had a stroke, or have you ever had a stroke yourself?
Consultant Neurologist,
T. P.A. tissue Plasminogen Activator Presented by: Kelly Banasky, RN, BSN GCH Emergency Services Educator.
What are we consulting on?
Thrombolysis East of England Forum
Assessment in the Emergency Department Dr Jeff Keep Consultant in Emergency Medicine & Major Trauma King’s College Hospital.
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Stroke and the ED Kurian Thomas, MD Department of Neurology.
The Evolving Management of Pediatric Stroke Christopher A. Miller, MD July 21, 2012.
10 May 2005 CASES - Original article available at CASES (Canadian Alteplase for Stroke Effectiveness Study) The CASES Investigators.
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.
Chapter 13 Neurologic Emergencies. 13: Neurologic Emergencies Emergency Care and Transportation of the Sick and Injured, 8th Edition AAOS 2 Describe the.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) Screening and randomisation Mette Krag Dept. of Intensive Care 4131 Copenhagen University.
STROKE Lalith Sivanathan 2015 ADVANCED CONCEPTS IN EMERGENCY CARE (EMS 483)
Copenhagen University Hospital Rigshospitalet, Denmark
What is the outcome of Door-to-needle Time within 60minutes for acute ischemic stroke patients treat with t-PA? Chi-Ching Chen 1, Hui-Fen Huang 1, Yu-Ling.
COMPREHENSIVE STROKE CARE
Brain waves or brain drain Interactive case discussion Dr Jenny Vaughan and Dr Richard Perry Charing Cross Hospital Hammersmith Hospital Imperial College.
11 WAYS TO DECREASE DOOR TO NEEDLE TIME YOU CAN DO IT FASTER Jeff Nickel, MD FACEP ED Medical Director Parkview Regional Medical Center.
Dr Payam Sasannejad, Neurologist Assistant Professor of mums Intravenous thrombolytic therapy in acute ischemic stroke.
SAVING TIME, SAVING BRAIN A study into the assessment of out-of-hours stroke patients Louise Dawson, Julia Fordham & Lizzie Griffiths Foundation Doctors,
Simon Howard Medical Management of Acute Stroke. Fast Recognition of Stroke With sudden onset neurological symptoms: 'FAST' should be used to screen for.
ACUTE STROKE TREATMENT: An introduction Dec.2014
Stroke Protocol Time Lost Is Brain Lost!. Objective: Improve patient care & outcomes Offer a standard of care Increase efficiency Meet accreditation recommendations.
JUST GIVE IT: a 2 phase study to audit the Immediate Management of Patients with Proven or Suspected Neutropenic Sepsis by Ally Gruber Acute Oncology Clinical.
ResultsIntroduction Atrial Fibrillation (AF) affects 1.2% 1 of the population and 10% of those over the age of 75 2 It is the commonest arrhythmia in primary.
Inclusion/exclusion criteria and decision making on thrombolysis treatment in stroke. Dr Anthony Pereira Department of Neurology St George’s Hospital.
Adult Stroke 2010 AHA Guidelines for CPR and ECC
EMERGENT TREATMENT PROTOCOLS FOR STROKE BERT TONEY, M.D. DIRECTOR, EMERGENCY DEPARTMENT FORT SANDERS PARKWEST MEDICAL CENTER WAYNE BAXTER, PARAMEDIC DIRECTOR,
Risk of stroke at 3 months6 Expected Strokes at 3 months
Clinical Audit of Head CT in Stroke Alert Cases: Role of Radiology Resident and CT Technologist Awareness in improving Head CT reporting time K Hooda,
Copenhagen University Hospital Rigshospitalet, Denmark
Chiara Franchini, Anne Bruton , Cathy Limby Stroke Specialist Nurses
Target: Stroke Honor Roll
Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.
Updates in the Treatment of Acute Stroke
Thrombolysis therapy for Pulmonary Embolism
Søren Marker Jensen Dept. of Intensive Care 4131
STROKE AWARENESS MONTH
Presentation transcript:

“Door to Needle (DTN) Time in Stroke Thrombolysis” Audit Care of the Elderly Department Dr Nikoletta Petrou, Foundation Year 1 Doctor Dr Prasanna Aghoram, Consultant Physician in Stroke Medicine

Reason for the Audit: Agreement in Stroke Network: Aim DTNt <60min This audit is a local initiative to measure current DTN times This audit aims to: ①Evaluate if appropriate patients are thrombolysed within 1 hour of A&E arrival ②Evaluate if patients with delayed DTN times have clear reasons for their delays ③Suggest appropriate action plans to improve patient care How did this Audit come about?

Stroke facts Every minute 1.9 million neurons and 14 billion synapses are destroyed Every hour that treatment is delayed, the ischaemic brain ages 3.6 years Time = Brain The Golden hour No current NICE guidelines on DTN time in Stroke Thrombolysis Recommendations to date have been consistent re: DTN <60min American Heart Association/American Stroke Association: Get with the Guidelines® Joint Committee (USA) sets a standard of 80% for DTN <60min National Institute of Neurological Disorders and Stroke Brain Attack Coalition sets a standard of 80% for DTN <60min International Stroke Conference – Only 27% of patients have DTNt <60min G. Fonarow et al, University of California, Los Angeles (2011) “Time Lost is Brain Lost”

THROMBOLYSIS PATHWAY ➊ Arrival to A&E ➋ A&E assessment ➌ Stroke team notified ➍ Priority CT Head ➎ Stroke team Assessment ➏ CT scan performed ➐ CT report obtained ➑ Patient informed and consent obtained ➒ Reconstitution and drawing up of Alteplase ➓ Thrombolysis is initiated INCLUSION CRITERIA Clinical signs and symptoms of definite acute stroke Clear time of onset Presentation within 3 hrs of acute onset Haemorrhage excluded by CT scan Age years old NIHSS less than 25 Consent to treat (every effort must be made to contact next of kin) EXCLUSION CRITERIA Rapidly improving or minor stroke symptoms Stroke or serious head injury 3 months Major surgery, obstetrical delivery, external heart massage last 14 days, Seizure at onset of stroke Prior stroke and concomitant diabetes Severe haemorrhage last 21 days Increase bleeding risk History of central nervous damage (neoplasm, haemorrhage, aneurysm, spinal or intracranial surgery or haemorrhagic retinopathy) Blood pressure above 185 mmHg systolic or 110 mmHg diastolic Symptoms suggestive of SAH (even if CT is normal) Known clotting disorder Patient on heparin or warfarin Suspected iron deficient anaemia or thrombocytopenia Suspected hypoglycaemia or hyper glycaemia >3 mmol/l > 22 mmol/l Bacterial endocarditis, pericarditis Acute pancreatitis Ulcerative GI disease last 3 months, oesophageal varices, arterial- aneurysm, arterial/venous malformation. Severe liver disease including cirrhosis, acute hepatitis DTN The Golden Hour

Standard 1 Appropriate patients should have DTNt <60min Target 80% Exempted: patients in international trials and patients whose hypertension required immediate treatment to allow thrombolysis to be considered Standard 2 Patients with DTNt >60min should have a reason for the delay Target 80% Standards

Analysis of Stroke Database Demographics and Consultant Time of symptom onset Time of arrival to A&E Time of stroke team arrival Time of Head CT scan Time of Alteplase given Prior BP control noted DTNt was calculated Reasons for delay were noted Four categories of DTN: 90min delay Methods Audit tool

✘ Target of 80% was not met Standard 1 43 patients thrombolysed ** 30 included ** Median DTNt 85 min

10% had DTN <60min 13% had DTN <65min 17% had DTN <70min 27% had DTN <75min 63% had DTN <90min Analysis

●More patients are thrombolysed in under 90 min compared to previous years ●More patients are thrombolysed in under 75 min compared to previous years Results by Year

All patients with DTN time > 90min have clear reasons documented by the Consultant Minor time losses are spread across the pathway and not documented Standard 2 59% have identified reasons for delay

Analysis

Analysis No difference in service speed between day-time and “out of hours” service

●10% of patients were thrombolysed within 60min of arrival to A&E and 63% within 90min. ●Only 27% have DTNt<60min according to the largest study to-date. ●27% can be achieved by reducing pathway delays by 15min. ●15% had DTNt<60min in 2011, an improvement on previous years. ●100% of severe delays (DTNt>90min) have documented reasons and these are predominantly (75%) due to difficult-to-modify patient-related factors Conclusions

●Important to track minor delays that are usually spread across the pathway ●Priority is ensuring safety of treatment at all times ●In some cases the delay may be inevitable. Alternative is no treatment Conclusions

Action Plan ICE 2

Monitoring tool Important to start completing when the patient arrives in A&E to track potential time losses in real time

References American Heart Association/American Stroke Association (2011). The Get With The Guidelines®– Stroke (GWTG-Stroke) program. Website: Fonarow GC, Smith EE, Saver JL (2011). Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: Patient characteristics, hospital factors, and outcomes associated with door- to-needle times within 60 minutes. Circulation 2011: DOI: Mikita M (2011). Reducing Door-to-Needle Time for tPA Use Remains and Elusive Goal in Stroke Care. JAMA. 2011;305(13): Sinha D, et al (2009). Door-toNeedle Time for Stroke Thrombolysis. Reasons for delays at busy District General Hospital. Southend Hospital. Availble online at: Susan Boorman (2011). Thrombolysis Audit. Onset-to-alteplase time. Darent Valley Hospital, Audit Meeting September 2011

Thank you Questions?

THROMBOLYSIS PATHWAY ➊ Arrival to A&E ➋ A&E assessment ➌ Stroke team notified ➍ Priority CT Head ➎ Stroke team Assessment ➏ CT scan performed ➐ CT report obtained ➑ Patient informed and consent obtained ➒ Reconstitution and drawing up of Alteplase ➓ Thrombolysis is initiated INCLUSION CRITERIA Clinical signs and symptoms of definite acute stroke Clear time of onset Presentation within 3 hrs of acute onset Haemorrhage excluded by CT scan Age years old NIHSS less than 25 Consent to treat (every effort must be made to contact next of kin) EXCLUSION CRITERIA Rapidly improving or minor stroke symptoms Stroke or serious head injury 3 months Major surgery, obstetrical delivery, external heart massage last 14 days, Seizure at onset of stroke Prior stroke and concomitant diabetes Severe haemorrhage last 21 days Increase bleeding risk History of central nervous damage (neoplasm, haemorrhage, aneurysm, spinal or intracranial surgery or haemorrhagic retinopathy) Blood pressure above 185 mmHg systolic or 110 mmHg diastolic Symptoms suggestive of SAH (even if CT is normal) Known clotting disorder Patient on heparin or warfarin Suspected iron deficient anaemia or thrombocytopenia Suspected hypoglycaemia or hyper glycaemia >3 mmol/l > 22 mmol/l Bacterial endocarditis, pericarditis Acute pancreatitis Ulcerative GI disease last 3 months, oesophageal varices, arterial- aneurysm, arterial/venous malformation. Severe liver disease including cirrhosis, acute hepatitis DTN The Golden Hour